 |
 |
PharmaVOICE - March 2009 Defining GLOBAL By Denise Myshko and Robin Robinson For more than 300 years, the word global has been used as an adjective to describe “pertaining to the whole world; worldwide; universal.” Today, global is defined by markets, patient populations, corporate structures and models, and business opportunities. We asked thought leaders who represent a wide variety of company types and industry sectors to provide their world view on what global means to them and to their businesses. This overview of the different aspects of global is followed by in-depth analysis of what operating globally means in terms of business, development, regulations, as well as marketing. We hope this first annual special issue provides you with a few perspectives on some of the trends and factors impacting the worldwide life-sciences... Sidebar: Global Outlook for 2009 Company Executives — What global means to their businesses and to them Experts on this topic Karla Anderson, Managing Director, Life Sciences, BearingPoint Leone Atkinson, M.D., Senior Director of Clinical Development, PTC Therapeutics Ajit Baid, Managing Director, The Research Partnership (USA) Hans Bishop, President, Specialty Medicine, Bayer HealthCare Pharmaceuticals Graham Bunn, VP, Global Partnerships and Alliances, Medidata Solutions Worldwide Jason Burke, Worldwide Director, Health and Life Sciences, SAS Brian Daleiden, Director of Marketing, SupplyScape Tim Dietlin, VP, Clinical Development Practice, Campbell Alliance Argelio Dumenigo, Senior Strategist, Razorfish Jean-Jacques Garaud, M.D., Global Head of Development and Chief Medical Officer, Roche Bruce Garrett, M.D., President and CEO, Global Research Services Mark Goldberg, M.D., Chief Operating Officer, Parexel International Howard Hassman, M.D., Chief Scientific Officer, CRI Worldwide Gerry Hepburn, President, Clinical Operations, Aptuit Bill Hook, VP, Global Strategy, Healthcare Logistics, UPS Jonathan Kay, Head of Brand Management, TNS Healthcare Tim Kelly, VP and Practice Leader, CIS, IMS Consulting, IMS Health Candace Kendle, Pharm.D., Chairman and CEO, Kendle Warren Levy, Ph.D., President and CEO, Unigene Bob Merold, General Manager, Symphony Metreo Pharma Liz Moench, President and Founder, MediciGlobal David Moskowitz, M.D., M.A., FACP, Chairman, CEO, and Chief Medical Officer, GenoMed Francois Nader, M.D., President and CEO, NPS Pharmaceuticals Karen Politis-Virk, M.S., Director of Biotech and Pharmaceutical Research, Language Connections Eric Rambeaux, VP, Business Strategy and Portfolio, Solvay Adam Serody, Senior Director, Business Development, PharmaNet Aize Smink, Executive VP, Project Management, Chiltern Bruce Thomas, Senior VP, MeadWestvaco Brad Thompson, Ph.D., Chairman, President, and CEO, Oncolytics Biotech Scott Treiber, Senior VP, Clinical Operations, inVentiv Clinical Alfonso Ugarte, Senior VP, Global Marketing, Stiefel Laboratories Mandi Walters, Senior Director, Business Development, PharmaNet Lori Webber, Senior VP and Chief Marketing Officer, SupplyScape Derek Winstanly, MB ChB, Executive VP, Strategic Business Partnerships, Quintiles Transnational Ray Wodar, Director of Life Sciences and Industry Strategy, Enovia, Dassault Systèmes
|
